Read ASX Announcement Here Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) has announced that it has entered into a clinical trial collaboration and supply agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as…
Summary by Millie Dwyer, Student Intern This BioMelbourne Network BioBreakfast event hosted at St Vincent’s launched the Victorian Clinical Trials Gateway and discussed Victoria’s clinical trial landscape. The event explored Victoria’s strengths and weaknesses in this field, inspiring…
MTPConnect – the Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – has released new sector metrics that show jobs supported by the MTP sector increased by 10% to 62,000 from 2015 to 2016, and that manufacturing…
– Stakeholders debate future of medicines funding system at launch event A new report, developed by GlaxoSmithKline Australia (GSK) and ViiV Healthcare (ViiV) will be launched as part of an initiative to raise understanding of the medicines development…
The Victorian Government in collaboration with Johnson & Johnson Innovation JLABS today announced the Victorian QuickFire Challenge, a competition giving healthcare entrepreneurs the chance to transform their ground-breaking research into the products that will advance the well-being of people around…
The new Johnson & Johnson Innovation Partnering Office at Monash (JJIPO@MONASH) was officially opened today by the Victorian Health Minister, Jill Hennessy at Monash University in Clayton. The office will serve as Johnson & Johnson Innovation’s local base…
Korean nutritional supplement producer Nutribiotech has chosen Australia as the location for its newest global manufacturing facility, creating 150 new full-time jobs over the next three years. Nutribiotech makes vitamins, minerals and nutritional supplements for several major Australian…
Doug Ferguson, KPMG’s National Managing Partner Asia & International Markets, discusses the latest trends from KPMG’s Demystifying Chinese Investment in Australian Healthcare report. Chinese investment in Australian healthcare companies has surged over the past three years. AUD5.5 billion has flowed…
Innovation and Science Australia (ISA) has challenged Australians, and their governments, to be bolder in using innovation to unlock economic and social opportunity for the future. The call came as ISA Chair, Mr Bill Ferris AC, launched Australia…
Our vision for Victoria is to lead the world in health innovation. Discovering, developing and manufacturing the health technologies that change the world. New drugs, devices, diagnostics, vaccines, therapies and digital products – Victoria is the best place to…
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products 4 December 2017, Melbourne: Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), is pleased to announce the signing of a non-exclusive license agreement with Rodan…
The Turnbull Government will invest $640 million to support Australia’s world-leading health and medical researchers as they continue their work in the laboratory, clinic and the community to find the next major medical breakthrough. Cancer research continues to…